Ads
related to: keytruda immunotherapy- Side Effects
Learn About Possible Side Effects
at the Official Patient Site.
- What Is KEYTRUDA?
Learn About What KEYTRUDA Is & How
It May Help Eligible Patients.
- Taking KEYTRUDA?
Learn What to Expect When
Taking KEYTRUDA.
- Clinical Trial Results
See Clinical Trial Results
at the Official Site.
- Treatment Options
Learn About Treatment
Options With KEYTRUDA.
- Get Financial Help
Find Assistance and Payment
Information for Eligible Patients.
- Side Effects
Search results
Merck stops skin cancer combination therapy testing in late-stage study
KFGO· 4 days ago(Reuters) -Merck has discontinued testing a combination of an experimental antibody-based drug and...
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters via AOL· 4 days agoThis is the latest setback for the experimental drug, vibostolimab, and the related promising new...
Merck halts research on combo drug for skin cancer
Becker’s Hospital Review· 4 days agoMerck will stop testing an experimental combination treatment for skin cancer patients in a late-stage study, the drugmaker said May 13. Merck was evaluating the use of the investigational & ...
Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations
FierceBiotech· 4 days agoMerck & Co. has bailed early on a phase 3 test of the anti-TIGIT antibody vibostolimab after a high...
...Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab)...
Benzinga· 4 days agoOSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that
PDS Biotechnology Corp. (NASDAQ:PDSB) Uses Cancer Immunotherapy to Infiltrate and Disable Tumors...
The Wall Street Transcript· 3 days agoPDS Biotechnology is a mid- to late-stage clinical development company working in the area of cancer...
ImmunityBio Advances On the Anktiva Front
Los Angeles Business Journal· 4 days agoImmunityBio Inc., the Culver City-based immunotherapy company founded by billionaire Patrick Soon-Shiong that last month won Food and Drug Administration approval for its ...
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer
MedPage Today· 3 days agoCheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death
Medicenna Provides Update on its Presentations at the 2024 ASCO Annual Meeting
Digital Journal· 4 days agoASCO has informed the Company that the previously accepted MDNA11 oral abstract has been withdrawn due to alleged violation of their prior publication policy based solely on their review of ...
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
Morningstar· 3 days ago("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, and Kayak Mergeco, Inc., Kintara's ...
Ads
related to: keytruda immunotherapy
